Combivent
Combivent, a combination of ipratropium bromide and albuterol sulfate, is a medication approved for the treatment of chronic obstructive pulmonary disease. This medication is prescribed to COPD patients who are on a regular aerosol bronchodilator but continue to have bronchospasms and therefore require a second bronchodilator. The presence of two different types of medications in Combivent helps to open airways in the lungs that aid COPD patients in breathing. Combivent Respimat is a suitable alternative to Combivent Inhalation Aerosol distributed by its marketer Boehringer Ingelheim.